Novel Strategies to Reduce Femoropopliteal Restenosis: Low-Dose Paclitaxel-Coated Balloons and Paclitaxel-Coated Balloons Plus Stenting

Affiliations

¹ From Lifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, RI.
² From Lifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, RI. herbert.aronow@lifespan.org.

Editorial

Andrew M Goldsweig et al. Circulation. 2017.

. 2017 Jun 6;135(23):2237-2240.

doi: 10.1161/CIRCULATIONAHA.117.028308. Epub 2017 Apr 19.

¹ From Lifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, RI.
² From Lifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, RI. herbert.aronow@lifespan.org.

No abstract available

Keywords: Editorials; balloon angioplasty; femoral artery; paclitaxel; peripheral arterial disease; stents.

Comment on

Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH).
Ott I, Cassese S, Groha P, Steppich B, Hadamitzky M, Ibrahim T, Kufner S, Dewitz K, Hiendlmayer R, Laugwitz KL, Schunkert H, Kastrati A, Fusaro M. Ott I, et al. Circulation. 2017 Jun 6;135(23):2218-2226. doi: 10.1161/CIRCULATIONAHA.116.025329. Epub 2017 Apr 19. Circulation. 2017. PMID: 28424222 Clinical Trial.
Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H, Werner M, Meyer DR, Reimer P, Krüger K, Jaff MR, Brodmann M; ILLUMENATE EU RCT Investigators. Schroeder H, et al. Circulation. 2017 Jun 6;135(23):2227-2236. doi: 10.1161/CIRCULATIONAHA.116.026493. Epub 2017 Apr 19. Circulation. 2017. PMID: 28424223 Free PMC article. Clinical Trial.